Mark joined in KPMG China in 2008 where he advises clients on investments in China including due diligence, joint ventures, vendor assistance, SPA drafting and completion accounts. Mark has extensive transaction service experiences in pharmaceutical & healthcare, consumer markets, industrial markets in China, granting his in-depth knowledge of sector characteristics and client’s primary concerns.
Automotive
Chemicals and Performance Technologies
Energy and Natural Resources
Food, Drink and Consumer Goods
Healthcare
Industrial Manufacturing
Infrastructure
Life Sciences
Pharmaceuticals
Retail
Member of the Institute of Chartered Accountants in England and Wales